1. Home
  2. ATPC vs LYRA Comparison

ATPC vs LYRA Comparison

Compare ATPC & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agape ATP Corporation

ATPC

Agape ATP Corporation

HOLD

Current Price

$0.09

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Logo Lyra Therapeutics Inc.

LYRA

Lyra Therapeutics Inc.

HOLD

Current Price

$3.80

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATPC
LYRA
Founded
2016
2005
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ATPC
LYRA
Price
$0.09
$3.80
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
77.0M
27.3K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,484,905.00
$600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.90
P/E Ratio
N/A
N/A
Revenue Growth
9.66
N/A
52 Week Low
$0.05
$2.84
52 Week High
$2.93
$37.50

Technical Indicators

Market Signals
Indicator
ATPC
LYRA
Relative Strength Index (RSI) 21.71 49.64
Support Level $0.09 $2.99
Resistance Level $0.11 $3.70
Average True Range (ATR) 0.01 0.26
MACD 0.03 0.05
Stochastic Oscillator 5.59 66.16

Price Performance

Historical Comparison
ATPC
LYRA

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: